Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
76.85
-68.14
-88.67%
Share Warrants & Outstandings
Total Reserve
1.65
7.31
-5.66
-77.43%
Shareholder's Funds
10.35
84.16
-73.81
-87.70%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
5.38
0.18
5.20
2,888.89%
Secured Loans
1.02
0.00
1.02
0.00%
Unsecured Loans
4.37
0.18
4.19
2,327.78%
Deferred Tax Assets / Liabilities
0.09
0.00
0.09
0.00%
Other Long Term Liabilities
0.88
2.46
-1.58
-64.23%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
4.16
2.63
1.53
58.17%
Current Liabilities
Trade Payables
2.06
3.82
-1.76
-46.07%
Other Current Liabilities
1.87
0.61
1.26
206.56%
Short Term Borrowings
7.84
0.00
7.84
0.00%
Short Term Provisions
0.00
0.06
-0.06
-100.00%
Total Current Liabilities
11.77
4.49
7.28
162.14%
Total Liabilities
26.28
91.28
-65.00
-71.21%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.71
0.21
3.50
1,666.67%
Less: Accumulated Depreciation
0.82
0.16
0.66
412.50%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.89
0.05
2.84
5,680.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.04
3.31
-3.27
-98.79%
Long Term Loans & Advances
0.00
10.59
-10.59
-100.00%
Other Non Current Assets
0.00
1.99
-1.99
-100.00%
Total Non-Current Assets
2.93
15.93
-13.00
-81.61%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.78
9.87
-3.09
-31.31%
Sundry Debtors
10.69
26.69
-16.00
-59.95%
Cash and Bank
1.24
0.40
0.84
210.00%
Other Current Assets
0.52
28.00
-27.48
-98.14%
Short Term Loans and Advances
4.12
10.40
-6.28
-60.38%
Total Current Assets
23.35
75.35
-52.00
-69.01%
Net Current Assets (Including Current Investments)
11.58
70.86
-59.28
-83.66%
Total Current Assets Excluding Current Investments
23.35
75.35
-52.00
-69.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.28
91.28
-65.00
-71.21%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
8.84
0.18
8.66
4,811.11%
Book Value per share (adjusted)
12.39
1.12
11.27
1,006.25%
Annual - Borrowings
Borrowings 11.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024
Annual - Fixed Assets
Fixed Assets 2.89 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024
Annual - Investments
Investments 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024
Annual - Current Assets
Current Assets 23.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024






